to main content
Portrait of Rohit Goswamy, MD, Oncology specialist at Kelsey-Seybold Clinic.
My Video Profile

Ways to Schedule an Appointment

  • About the Provider
  • Education & Board Certification
  • Professional Associations

Rohit Goswamy, MD, is a board-certified hematologist/oncologist who attended Royal College of Surgeons in Ireland, earning his medical degree in 2017. He then relocated to the US, completing his internship and Internal Medicine residency at McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth), serving as chief resident his final year in 2021. Dr. Goswamy also completed a fellowship in Hematology and Oncology at Emory University in 2025 before joining Kelsey-Seybold in August 2025.

Inspired to pursue medicine by his family, and his mother especially, Dr. Goswamy specializes in the diagnosis and treatment of all cancer conditions as well as non-malignant hematological conditions such as hemophilia, sickle cell disease, platelet disorders, and more. His favorite aspect of practicing medicine is having the opportunity to get to know his patients and make a difference in their lives.

Philosophy of Care

Dr. Goswamy knows that patients are more than their disease; they are individuals who deserve holistic care. In order to provide the best treatment, he uses a tailored, patient-centric approach focused on optimal outcomes.

Hobbies & Interests

In his free time, Dr. Goswamy enjoys running, playing tennis and soccer, and exploring the diverse flavors of Asian cuisine.

Joined Kelsey-Seybold: August 2025

Awards & Publications

Awards

  • UTHealth McGovern Medical School Chief Resident (2022)
  • Alpha Omega Alpha Medical Honor Society (2021)
  • Internal Medicine Chief Resident (2022)
  • Institute for Healthcare Improvement Certificate in Quality and Safety (2021)

Publications

Goswamy, R., Kalemoglu, E., Master, V., & Bilen, M. A. (2024). Perioperative systemic treatments in renal cell carcinoma. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1362172

Pilie PG, Giuliani V, Wang WL, McGrail DJ, Bristow CA, Ngoi NYL, Kyewalabye K, Wani KM, Le H, Campbell E, Sánchez NS, Yang D, Gheeya JS, Goswamy RV, Holla V, Shaw KR, Meric-Bernstam F, Liu CY, Ma X, Feng N, Machado AA, Bardenhagen JP, Vellano CP, Marszalek JR, Rajendra E, Piscitello D, Johnson TI, Likhatcheva M, Elinati E, Majithiya J, Neves J, Grinkevich V, Ranzani M, Roy-Luzarraga M, Boursier M, Armstrong L, Geo L, Lillo G, Tse WY, Lazar AJ, Kopetz SE, Geck Do MK, Lively S, Johnson MG, Robinson HMR, Smith GCM, Carroll CL, Di Francesco ME, Jones P, Heffernan TP, Yap TA. Ataxia-Telangiectasia Mutated (ATM) loss of function displays variant and tissue-specific differences across tumor types. Clin Cancer Res. 2024 Feb 28. doi: 10.1158/1078-0432.CCR-23-1763. Epub ahead of print. PMID: 38416404.

Goswamy R, Ajufo H, Maiti A, Brown R, Juneja H, Apostolidou E. Refractory Hydroa Vacciniforme-like Lymphoma: Biological Insights from Morphoproteomic Analysis. Int J Hematol Oncol Stem Cell Res. 2022 Jul 1;16(3):177-183. PMID: 36694700; PMCID: PMC9831872.

Siddiqui BA, Gheeya JS, Goswamy R, Bathala TK, Surasi DS, Gao J, Shah A, Campbell MT, Msaouel P, Goswami S, Wang J, Zurita AJ, Jonasch E, Corn PG, Aparicio AM, Siefker-Radtke AO, Sharma P, Subudhi SK, Tannir N. Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events. J Immunother Cancer. 2021 Jul;9(7):e002850. doi: 10.1136/jitc-2021-002850. PMID: 34326169; PMCID: PMC8323401.

Goswamy RV, Wilson NR, Tannenbaum DJ, Aung FM, Hernandez CMR. Practice patterns and clinical outcomes of platelet alloimmunization in a comprehensive cancer center. Transfus Apher Sci. 2021 Jun;60(3):103096. doi: 10.1016/j.transci.2021.103096. Epub 2021 Feb 13. PMID: 33612449.

Maiti A, Kantarjian HM, Popat V, Borthakur G, Garcia-Manero G, Konopleva MY, DiNardo CD, Verstovsek S, Andreeff M, Kadia TM, Ajufo HO, Goswamy RV, Blanco C, Velasquez M, Daver NG, Pemmaraju N, Pierce SR, Wierda WG, Kornblau SM, Ravandi F, Cortes JE. Clinical value of event-free survival in acute myeloid leukemia. Blood Adv. 2020 Apr 28;4(8):1690-1699. doi: 10.1182/bloodadvances.2019001150. PMID: 32330243; PMCID: PMC7189295.

Schmelz JL, Navsaria L, Goswamy R, Chuang HH, Miranda RN, Lee HJ. Chimeric antigen receptor T-cell therapy's role in antiphospholipid syndrome: a case report. Br J Haematol. 2020 Feb;188(3):e5-e8. doi: 10.1111/bjh.16266. Epub 2019 Nov 13. PMID: 31721157.

Goswamy RV, Maiti A, Escobar MA. Unnecessary Use of Inferior Vena Cava Filters: A Teachable Moment. JAMA Intern Med. 2017 Dec 1;177(12):1847-1848. doi: 10.1001/jamainternmed.2017.3991. PMID: 29049483.

Medical School

  • Royal College of Surgeons – Dublin, Ireland, 2017

Internship/Residency

  • McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth) – Houston, TX, 2021;

Board Certifications

  • American Board of Internal Medicine - Medical Oncology
Dr. Goswamy is a member of the American Society of Clinical Oncology, American Society of Hematology, and American College of Physicians.

Locations

Berthelsen Main Campus

2727 W. Holcombe Blvd.,
Houston, TX 77025

Get Directions 713-442-0000

Bay Area Campus

1010 S. Ponds Dr.,
Webster, TX 77598

Get Directions 713-442-4300

Hospital Affiliations

  • Baylor St Lukes Medical Center - McNair Campus

Accepted Insurance